dMed

About:

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.

Website: http://www.dmedglobal.com/

Top Investors: Fidelity, Qiming Venture Partners, HongShan, Legend Capital, Kaiser Permanente

Description:

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

Total Funding Amount:

$214M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2016-08-01

Founders:

Lingshi Tan

Number of Employees:

501-1000

Last Funding Date:

2021-07-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai